Thu, Jan 29, 2015, 6:14 AM EST - U.S. Markets open in 3 hrs 16 mins


% | $
Quotes you view appear here for quick access.

Walgreen Co. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • cmxgen cmxgen Oct 25, 2011 6:14 PM Flag

    95% Estimate

    I thought it was 97%...ESRX also states 0 to 2% rx growth next year.

    esrx will do fine. lets see what cvs says or suggests rx volume will move up.

    This might be hard to stomach if you are a WAG shareholder.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I don't see ESRX comments as newsworthy to sophisticated shareholders of either company. As you well know, WAG takes a big hit on the front end and ESRX deteriorates gradually for 2 years. The net effect is good for CVS and bad for WAG and ESRX. If ESRX/MHS merger goes through, ESRX may be facing several weak quarters. It's funny also that WAG, while attempting to move Part D business away from ESRX, is strongly promoting it's partnership with Coventry MPD which is a Medco product. Certainly a potential backfire there. The fact that they continue to push Coventry is part of the reason I think WAG plans to ink a contract. Either that or they think the merger won't happen. Time will tell.


Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Facebook, Inc.
NASDAQWed, Jan 28, 2015 4:00 PM EST
Nokia Corporation
NYSEWed, Jan 28, 2015 4:01 PM EST